ClinicalTrials.gg
RecruitingNCT03470246PACOUpdated Aug 15, 2019

Personalized Activity Intervention in Rehabilitation After Cardiac Operations (the PACO Trial)

An interventional study of PACO intervention for CABG patients and PACO intervention for AVR patients in Coronary Artery Disease, Aortic Valve Stenosis and Mitral Valve Insufficiency, sponsored by Kuopio University Hospital. Recruiting at 1 site in Finland. Open to participants aged 30 Years to 90 Years. Per ClinicalTrials.gov, last updated 2019-08-15.

Sponsored by Kuopio University Hospital · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Primary completion was expected by Jan 2022, 4 years 10 months ago, but the record still lists the study as recruiting.
  • Started Apr 2018; still recruiting 8 years 7 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
540
Allocation
Randomized
Ages
30 Years to 90 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 55 studies in Coronary Artery Disease with a site in Finland — 13 open to participants now, 18 under way, none of them phase 3. Coronary Artery Disease · Finland.

Planned enrollment
17th of 37
540 · median 294
Started
2018
with 5 others
No phase
21 of 55
6 open now
Primary completion
2022-01
later than 1 of 17 live
Registered
32nd of 55
by date
Lead sponsor
3 of 55
Kuopio University Hospital

Among the 55 studies in Coronary Artery Disease with a site in Finland, this one is the 17th largest by planned enrollment of the 37 interventional ones that give a count, is one of 6 that started in 2018, is one of 21 with no phase, reaches primary completion later than 1 of the 17 other live ones, and was the 32nd registered.

Coronary Artery Disease

4,866 studies on the registry are indexed under Coronary Artery Disease; 892 are open to participants now.

Browse Coronary Artery Disease studies →

Open to participants now

13 of the 55 studies in Coronary Artery Disease with a site in Finland are open now. Recruiting first, the newest first:

7 more — sign in →

All 13 open studies →

A study can be open while its sites in Finland have not opened yet or have stopped. Only those recruiting at a site in Finland →

Who these studies take

Of the 591 Coronary Artery Disease studies recruiting now, 404 (68%) set no upper age limit and 68 (12%) stop at 75 or younger; 37 take children under 18; 49 take healthy volunteers.

This study: 30 Years to 90 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 55 studies in Coronary Artery Disease with a site in Finland, or all of them as a file.
02

Study summary

The PACO trial is a randomized clinical trial conducted in Heart Centers of Kuopio and Turku university hospitals. The coronary artery disease, aortic valve stenosis and mitral valve insufficiency patients preparing for elective coronary artery bypass grafting (CABG), aortic valve replacement (AVR) or mitral valve repair (MVR) will be randomized to either intervention or control group. The specific operation groups (CABG, AVR and MVR) will be analyzed separately. The 7-day baseline measurements of sedentary behaviour (SB), physical activity (PA) and sleep will be conducted to the patients by using the RM42 accelerometer during the pre-operative month.

After the cardiac procedure is completed and the patient is moved to post-operative ward, the control group patients will begin the standard post-operative rehabilitation program of the participating hospitals (activity guidance given by a physiotherapist). Patients in the intervention groups will follow the identical program but after discharge they will also receive personalized activity guidance through the combination of ExSed smart phone application, Suunto MoveSense accelerometer and cloud system during the first 90 days of post-operative rehabilitation. Weekly evolving daily goals to replace SB with PA (daily goals for steps, moderate PA, light PA and standing, and sitting time limit) will be designed for each patient of the intervention groups. A new daily step goal will be delivered from the cloud system to the patient's smart phone in the beginning of each week of the intervention. The daily step goal of the first intervention week is based on patient's walking distance assessed by a physiotherapist in post-operative ward. The following goals will be automatically evolved in the basis of patient's personal average step count of the previous week. The MoveSense accelerometer will measure accumulated levels of SB, PA and sleep, and transmit the data to user's ExSed application with Bluetooth. With information about accumulated levels of SB and PA, the application is able to guide the patient to accomplish the predefined activity goal. The guidance and motivation will be offered with pop-up notifications and histograms (columns are fulfilled according to patient's accumulated daily activity). The researches retain a remote access to the activity data of patients in the cloud system. The ExSed application will be connected to the cloud system with internet connection.

In addition, the patients of the intervention groups will receive short video files (lasting from 1 to 3 minutes) containing exercise guidance from a physiotherapist specialized to cardiac operation patients. These videos are available on the ExSed application during the intervention. The physiotherapist will also contact each patient (by mobile phone) with structured contact form from 1 to 4 times in a month to make sure that the intervention is proceeding as designed.

03

Conditions studied

  • Coronary Artery Disease
  • Aortic Valve Stenosis
  • Mitral Valve Insufficiency

Keywords

  • Accelerometer
  • Aortic valve replacement
  • Aortic valve stenosis
  • Coronary artery bypass grafting
  • Coronary artery disease
  • eHealth
  • Interactive guidance
  • Mitral valve insufficiency
  • Mitral valve repair
  • Rehabilitation
04

Who can participate

Ages eligible
30 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • An eligible patient with coronary artery disease, aortic valve stenosis or mitral valve insufficiency scheduled for elective coronary artery bypass grafting, aortic valve replacement or mitral valve repair operation.
  • He / she does not have any severe disease or functional limitation limiting PA (other than CVD).
  • He / she is willing to wear a hip- and wrist-worn accelerometer.
  • He / she is willing and capable to use a smart phone application.

Exclusion criteria

Exclusion Criteria:

  • He / she ends up in prolonged intensive care after cardiac operation.
  • He / she has a memory disorder (i.e. Alzheimer's disease).
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
540 participants (estimated)

Study arms

  • No intervention
    CABG control group

    The group of coronary artery disease patients receiving the standard postoperative rehabilitation of Kuopio and Turku university hospitals after coronary artery bypass grafting. The post-operative rehabilitation includes written and oral physical activity guidance from a physiotherapist.

  • Experimental
    PACO intervention for CABG patients

    The group of coronary artery disease patients receiving the PACO intervention for CABG patients besides the standard postoperative rehabilitation of Kuopio and Turku university hospitals after coronary artery bypass grafting. The PACO intervention includes activity guidance (i.e. goals to improve daily steps and physical activity levels, and reduce prolonged sitting) provided to the patients with the novel combination of ExSed application, MoveSense accelerometer and cloud system. In addition, exercise guidance (short video files) and regular mobile phone contacts from physiotherapist will be included to the intervention.

    Behavioral: PACO intervention for CABG patients

  • No intervention
    AVR control group

    The group of aortic valve stenosis patients receiving the standard postoperative rehabilitation of Kuopio and Turku university hospitals after aortic valve replacement. The post-operative rehabilitation includes written and oral physical activity guidance from a physiotherapist.

  • Experimental
    PACO intervention for AVR patients

    The group of aortic valve stenosis patients receiving the PACO intervention for AVR patients besides the standard postoperative rehabilitation of Kuopio and Turku university hospitals after aortic valve replacement. The PACO intervention includes activity guidance (i.e. goals to improve daily steps and physical activity levels, and reduce prolonged sitting) provided to the patients with the novel combination of ExSed application, MoveSense accelerometer and cloud system. In addition, exercise guidance (short video files) and regular mobile phone contacts from physiotherapist will be included to the intervention.

    Behavioral: PACO intervention for AVR patients

  • No intervention
    MVR control group

    The group of mitral valve insufficiency patients receiving the standard postoperative rehabilitation of Kuopio and Turku university hospitals after mitral valve repair. The post-operative rehabilitation includes written and oral physical activity guidance from a physiotherapist.

  • Experimental
    PACO intervention for MVR patients

    The group of mitral valve insufficiency patients receiving the PACO intervention for MVR patients besides the standard postoperative rehabilitation of Kuopio and Turku university hospitals after mitral valve repair. The PACO intervention includes activity guidance (i.e. goals to improve daily steps and physical activity levels, and reduce prolonged sitting) provided to the patients with the novel combination of ExSed application, MoveSense accelerometer and cloud system. In addition, exercise guidance (short video files) and regular mobile phone contacts from physiotherapist will be included to the intervention.

    Behavioral: PACO intervention for MVR patients

Interventions

  • BehavioralPACO intervention for CABG patients

    The PACO intervention is based on post-operative guidance to replace prolonged SB with PA in the rehabilitation of patients recovering from coronary artery bypass grafting (CABG). The guidance will be provided to the patients with the combination of ExSed smart phone application, accelerometer and cloud system. In addition, exercise guidance (short video files) and regular mobile phone contacts from physiotherapist will be provided to the intervention patients.

  • BehavioralPACO intervention for AVR patients

    The PACO intervention is based on post-operative guidance to replace prolonged SB with PA in the rehabilitation of patients recovering from aortic valve replacement (AVR). The guidance will be provided to the patients with the combination of ExSed smart phone application, accelerometer and cloud system. In addition, exercise guidance (short video files) and regular mobile phone contacts from physiotherapist will be provided to the intervention patients.

  • BehavioralPACO intervention for MVR patients

    The PACO intervention is based on post-operative guidance to replace prolonged SB with PA in the rehabilitation of patients recovering from mitral valve repair (MVR). The guidance will be provided to the patients with the combination of ExSed smart phone application, accelerometer and cloud system. In addition, exercise guidance (short video files) and regular mobile phone contacts from physiotherapist will be provided to the intervention patients.

06

What researchers measure

Primary outcomes

  1. Improvement in mean daily number of steps

    The improvement in mean daily number of steps after 3 months from discharge. In addition, the follow-up will be continued until 12 months after discharge. The baseline values of mean daily number of steps will be determined in a 7-day accelerometer measurements conducted to the patients before the elective cardiac operation. The mean daily number of steps after the first 3 and 12 months of post-operative rehabilitation at home will be also determined in 7-day (24 h) accelerometer measurements. The raw accelerometer data will be analyzed with Mean Amplitude Deviation and Angle for Posture Estimation -algorithms to recognize the daily steps for the 7 days of which average will be calculated for each study patient.

    Time frame: Improvement between baseline (during the last preoperative month) and first 3 (and 12) months after discharge.

Secondary outcomes

  1. Change in mean daily accumulated total time of light PA and MVPA

    The post-operative change in patient's mean daily accumulated total time of light and moderate to vigorous physical activity.

    Time frame: Change between baseline (during the last preoperative month) and first 3 months after discharge.

  2. Change in mean daily total time of sedentary behaviour (SB)

    The post-operative change in patient's mean daily total time of SB.

    Time frame: Change between baseline (during the last preoperative month) and first 3 months after discharge.

  3. Change in maximal oxygen consumption

    The evolvement of patient's maximal oxygen consumption (VO2 peak) will be determined in 6 minute walking test, conducted to the patients twice (after 1 and 3 months) post-operatively. Only a part of the randomized patients coming from city areas of Kuopio and Turku will be included to the measurements of maximal oxygen consumption.

    Time frame: Change between the first and third months after discharge.

  4. Improvement in self-perceived quality of life (QoL) assessed with SAQ-7 -questionnaire

    The improvement in patient's post-operative quality of life after 3 months of rehabilitation. The quality of life will be determined with Seattle Angina Questionnaire 7 (SAQ-7).

    Time frame: Improvement between baseline (during the last preoperative month) and first 3 months after discharge.

  5. Improvement in self-perceived quality of life (QoL) assessed with SF-36 -questionnaire

    The improvement in patient's post-operative quality of life after 3 months of rehabilitation. The quality of life will be determined with SF-36 -questionnaire.

    Time frame: Change between baseline (during the last preoperative month) and first 3 months after discharge.

  6. Improvement in self-perceived quality of life (QoL) assessed with 15 D -questionnaire

    The improvement in patient's post-operative quality of life after 3 months of rehabilitation. The quality of life will be determined with 15 D -questionnaire.

    Time frame: Improvement between baseline (during the last preoperative month) and first 3 months after discharge.

  7. Improvement in self-perceived quality of life (QoL) assessed with PHQ-2 -questionnaire

    The improvement in patient's post-operative quality of life after 3 months of rehabilitation. The quality of life will be determined with PHQ-2 -questionnaire.

    Time frame: Improvement between baseline (during the last preoperative month) and first 3 months after discharge.

  8. Improvement in self-perceived quality of life (QoL) assessed with Rose Dyspnea Index

    The improvement in patient's post-operative quality of life after 3 months of rehabilitation. The quality of life will be determined with Rose Dyspnea Index.

    Time frame: Improvement between baseline (during the last preoperative month) and first 3 months after discharge.

  9. Incidence of major cardiovascular events

    The major cardiovascular events include: all-cause mortality, any rehospitalizations due to CVD, repeat coronary revascularization, non-operational myocardial infarction and stroke. The incidence of major cardiovascular events will be monitored from the patient records of the hospitals and HILMO database during the first 12 post-operative months. In addition, patients will be asked about cardiovascular events during research telephone contact (after 12 months of rehabilitation).

    Time frame: The first 12 post-operative months

  10. Change in the accelerometer-derived portion of deep sleep

    The change in patient's deep sleep portion after cardiac operations. Deep sleep will be recognized with accelerometer attached to patient's wrist during sleep. Accelerometer will be used during 7 days.

    Time frame: Change between baseline (during the last preoperative month) and first 3 months after discharge.

  11. Change in heart rate variability

    The change in the heart rate variability.

    Time frame: Change between baseline (during the last preoperative month) and first 3 months after discharge.

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Vasankari S, Hartikainen J, Vasankari V, Anttila V, Tokola K, Vaha-Ypya H, Husu P, Sievanen H, Vasankari T, Halonen J. Objectively measured preoperative physical activity and sedentary behaviour among Finnish patients scheduled for elective cardiac procedures: baseline results from randomized controlled trial. BMC Sports Sci Med Rehabil. 2022 Jul 16;14(1):130. doi: 10.1186/s13102-022-00522-1. PubMed 35842711 ↗
  • Abraham LN, Sibilitz KL, Berg SK, Tang LH, Risom SS, Lindschou J, Taylor RS, Borregaard B, Zwisler AD. Exercise-based cardiac rehabilitation for adults after heart valve surgery. Cochrane Database Syst Rev. 2021 May 7;5(5):CD010876. doi: 10.1002/14651858.CD010876.pub3. PubMed 33962483 ↗
  • Vasankari V, Halonen J, Husu P, Vaha-Ypya H, Tokola K, Suni J, Sievanen H, Anttila V, Airaksinen J, Vasankari T, Hartikainen J. Personalised eHealth intervention to increase physical activity and reduce sedentary behaviour in rehabilitation after cardiac operations: study protocol for the PACO randomised controlled trial (NCT03470246). BMJ Open Sport Exerc Med. 2019 Jul 5;5(1):e000539. doi: 10.1136/bmjsem-2019-000539. eCollection 2019. PubMed 31354960 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2018 (actual). Primary completion is estimated for Jan 2022, 45 months after the start.

Of 756 non-industry interventional studies with no phase under Coronary Artery Disease, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 53. This study's planned 45 months is above that.

Counting every sponsor, half of 933 studies reached it within 30 months; a quarter within 15 and three quarters within 50.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 28, 2018
First posted
Mar 19, 2018
StartActual
Apr 6, 2018
Primary completionEst.
Jan 2022
CompletionEst.
Mar 1, 2028
Last update
Aug 15, 2019
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 15, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03470246
Collaborators
UKK Institute, Turku University Hospital
Responsible party
Sponsor
First posted
Mar 19, 2018
Start date
Apr 6, 2018
Primary completion
Jan 2022 (estimated)
Completion
Mar 1, 2028 (estimated)
Last update
Aug 15, 2019

Study contacts

Ville Vasankari, B.M. with thesis
Contact
villevas@uef.fi
505208148 ext. +358
Jari Halonen, M.D.; Ph.D.
Contact
jari.halonen@kuh.fi
405885829 ext. +358
Jari Halonen, M.D.; Ph.D.
principal investigator · Heart Center, Kuopio University Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion